Search

everythinglearnresearchcommunity

for

Search:↓

Lower SHBG levels may increase the risk of PCOS.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

People undergoing chemotherapy need better support and information to cope with hair loss.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

Combination therapies work better than single treatments for hair loss.

Low-level laser therapy safely and effectively improves hair growth and coverage for male and female pattern hair loss.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Azathioprine may help treat severe alopecia areata, but more research is needed.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Low levels of vitamin B12, ferritin, and calcium are linked to premature graying of hair.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.